<DOC>
	<DOCNO>NCT00359853</DOCNO>
	<brief_summary>Advanced liver disease low ascitic fluid protein concentration identify risk factor spontaneous bacterial peritonitis cirrhosis . Moreover , renal impairment hyponatremia increase mortality rate infection . Aims : To investigate oral administration norfloxacin prevents first episode SBP , hepatorenal syndrome improves survival cirrhotic patient ascites low protein concentration ascitic fluid ( &lt; 15 g/L ) least one follow inclusion criterion : functional renal failure ( serum creatinine ≥ 1,2 mg/dl BUN ≥ 25 mg/dl ) , hyponatremia ( serum sodium ≤ 130 mEq/L ) advance liver disease ( Child ≥ 9 point serum bilirubin ≥ 3 mg/dl ) . Methods : Prospective , multicenter , randomize , double-blind placebo control trial compare oral norfloxacin ( 400 mg/d ; n=35 ) placebo ( n=35 ) .</brief_summary>
	<brief_title>Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Peritonitis</mesh_term>
	<mesh_term>Hepatorenal Syndrome</mesh_term>
	<mesh_term>Norfloxacin</mesh_term>
	<criteria>Age 1880 year , protein concentration ascitic fluid &lt; 15 g/L least one following : serum creatinine ≥ 1.2 mg/dl BUN ≥ 25 mg/dl , serum sodium ≤ 130 mEq/L severe liver failure define ChildPugh score ≥ 9 point serum bilirubin ≥ 3 mg/dl . Previous history spontaneous bacterial peritonitis norfloxacin prophylaxis , allergy quinolones , hepatocellular carcinoma , organic renal failure HIV infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2004</verification_date>
	<keyword>Norfloxacin , primary prophylaxis , SBP</keyword>
</DOC>